112 related articles for article (PubMed ID: 11807603)
1. Use of 5-[(76)Br]bromo-2'-fluoro-2'-deoxyuridine as a ligand for tumour proliferation: validation in an animal tumour model.
Borbath I; Grégoire V; Bergström M; Laryea D; Långström B; Pauwels S
Eur J Nucl Med Mol Imaging; 2002 Jan; 29(1):19-27. PubMed ID: 11807603
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of [76Br]bromofluorodeoxyuridine and its validation with regard to uptake, DNA incorporation, and excretion modulation in rats.
Lu L; Bergström M; Fasth KJ; Langström B
J Nucl Med; 2000 Oct; 41(10):1746-52. PubMed ID: 11038007
[TBL] [Abstract][Full Text] [Related]
3. Rat studies comparing 11C-FMAU, 18F-FLT, and 76Br-BFU as proliferation markers.
Lu L; Samuelsson L; Bergström M; Sato K; Fasth KJ; Långström B
J Nucl Med; 2002 Dec; 43(12):1688-98. PubMed ID: 12468521
[TBL] [Abstract][Full Text] [Related]
4. Density centrifugation of murine fibrosarcoma cells following in situ labelling with tritiated thymidine.
Sigdestad CP; Grdina DJ
Cell Tissue Kinet; 1981 Nov; 14(6):589-600. PubMed ID: 7296625
[TBL] [Abstract][Full Text] [Related]
5. Cell kinetic analysis of murine squamous cell carcinomas: a comparison of single versus double labelling using flow cytometry and immunohistochemistry.
Schultz-Hector S; Begg AC; Hofland I; Kummermehr J; Sund M
Br J Cancer; 1993 Dec; 68(6):1097-103. PubMed ID: 8260360
[TBL] [Abstract][Full Text] [Related]
6. Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts.
Zätterström UK; Johansson M; Källén A; Baldetorp B; Oredsson S; Wennerberg J; Killander D
Cytometry; 1992; 13(8):872-9. PubMed ID: 1459003
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of thymidylate synthase by 2',2'-difluoro-2'-deoxycytidine (Gemcitabine) and its metabolite 2',2'-difluoro-2'-deoxyuridine.
Honeywell RJ; Ruiz van Haperen VW; Veerman G; Smid K; Peters GJ
Int J Biochem Cell Biol; 2015 Mar; 60():73-81. PubMed ID: 25562513
[TBL] [Abstract][Full Text] [Related]
8. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.
Wilson GD; McNally NJ; Dunphy E; Kärcher H; Pfragner R
Cytometry; 1985 Nov; 6(6):641-7. PubMed ID: 4064843
[TBL] [Abstract][Full Text] [Related]
9. In vitro and animal validation of bromine-76-bromodeoxyuridine as a proliferation marker.
Bergström M; Lu L; Fasth KJ; Wu F; Bergström-Pettermann E; Tolmachev V; Hedberg E; Cheng A; Långström B
J Nucl Med; 1998 Jul; 39(7):1273-9. PubMed ID: 9669410
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of mouse jejunum radiosensitization by 2',2'-difluorodeoxycytidine (gemcitabine) and its relationship with pharmacodynamics of DNA synthesis inhibition and cell cycle redistribution in crypt cells.
Grégoire V; Beauduin M; Rosier JF; De Coster B; Bruniaux M; Octave-Prignot M; Scalliet P
Br J Cancer; 1997; 76(10):1315-21. PubMed ID: 9374377
[TBL] [Abstract][Full Text] [Related]
11. 2',2'-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell lines.
Ruiz van Haperen VW; Veerman G; Vermorken JB; Peters GJ
Biochem Pharmacol; 1993 Aug; 46(4):762-6. PubMed ID: 8363650
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of 4'-[methyl-14C]thiothymidine for in vivo DNA synthesis imaging.
Toyohara J; Kumata K; Fukushi K; Irie T; Suzuki K
J Nucl Med; 2006 Oct; 47(10):1717-22. PubMed ID: 17015909
[TBL] [Abstract][Full Text] [Related]
13. Reporter gene imaging: effects of ganciclovir treatment on nucleoside uptake, hypoxia and perfusion in a murine gene therapy tumour model that expresses herpes simplex type-1 thymidine kinase.
Morin KW; Knaus EE; Wiebe LI; Xia H; McEwan AJ
Nucl Med Commun; 2000 Feb; 21(2):129-37. PubMed ID: 10758606
[TBL] [Abstract][Full Text] [Related]
14. In vitro studies on the immunosuppressive effect of 2',2'-difluorodeoxycytidine (dFdC) and its metabolite 2',2'-difluorodeoxyuridine (dFdU).
Tiefenthaler M; Hohla F; Irschick E; Strasser-Wozak E; Bacher N; Mühlmann O; Wein W; Konwalinka G
Immunobiology; 2003; 207(2):149-57. PubMed ID: 12675273
[TBL] [Abstract][Full Text] [Related]
15. Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine.
Dupertuis YM; Vazquez M; Mach JP; De Tribolet N; Pichard C; Slosman DO; Buchegger F
Cancer Res; 2001 Nov; 61(21):7971-7. PubMed ID: 11691821
[TBL] [Abstract][Full Text] [Related]
16. Double labelling of tissue combining tritiated thymidine autoradiography with immunodetection of bromodeoxyuridine: the autoradiographic significance of inhibition of thymidine incorporation into DNA by bromodeoxyuridine given simultaneously.
Hume WJ; Thompson J
Cell Tissue Kinet; 1989 Sep; 22(5):393-9. PubMed ID: 2611854
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of [3H]thymidine incorporation into DNA of rat regenerating liver by 2',2'-difluorodeoxycytidine coupled to lactosaminated poly-L-lysine.
Di Stefano G; Busi C; Mattioli A; Derenzini M; Trerè D; Fiume L
Biochem Pharmacol; 1999 Apr; 57(7):793-9. PubMed ID: 10075085
[TBL] [Abstract][Full Text] [Related]
18. The deaminated metabolite of gemcitabine, 2',2'-difluorodeoxyuridine, modulates the rate of gemcitabine transport and intracellular phosphorylation via deoxycytidine kinase.
Hodge LS; Taub ME; Tracy TS
Drug Metab Dispos; 2011 Nov; 39(11):2013-6. PubMed ID: 21832002
[TBL] [Abstract][Full Text] [Related]
19. Radiosensitization of mouse sarcoma cells by fludarabine (F-ara-A) or gemcitabine (dFdC), two nucleoside analogues, is not mediated by an increased induction or a repair inhibition of DNA double-strand breaks as measured by pulsed-field gel electrophoresis.
Grégoire V; Beauduin M; Bruniaux M; De Coster B; Octave Prignot M; Scalliet P
Int J Radiat Biol; 1998 May; 73(5):511-20. PubMed ID: 9652808
[TBL] [Abstract][Full Text] [Related]
20. The validity of the labelling index in tumour studies.
Hamilton E; Dobbin J
Br J Cancer; 1985 Jan; 51(1):15-21. PubMed ID: 3966970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
